C. Neff

发表

Analysis of Vaccinia Virus−Host Protein−Protein Interactions: Validations of Yeast Two-Hybrid Screenings

Joshua LaBaer, Leiliang Zhang, Nancy Y. Villa, 2009, Journal of proteome research.

Proteomic screening of variola virus reveals a unique NF-κB inhibitor that is highly conserved among pathogenic orthopoxviruses

G. McFadden, J. Lanchbury, I. Damon, 2009, Proceedings of the National Academy of Sciences.

Evidence for epistasis between SLC6A4 and a chromosome 4 gene as risk factors in major depression

V. Abkevich, D. Shattuck, D. Katz, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Homologous recombination deficiency (HRD) as an ovarian cancer biomarker in a real-world cohort - validation of decentralized genomic profiling.

C. Denkert, F. Marmé, P. Jank, 2022, The Journal of molecular diagnostics : JMD.

Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.

K. Baggerly, T. Conrads, A. Sood, 2021, Gynecologic oncology.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors

Z. Szallasi, I. Csabai, A. Eklund, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

Robert Brown, A. Gutin, H. Gabra, 2018, Molecular Cancer Research.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors

Z. Szallasi, I. Csabai, A. Eklund, 2018, bioRxiv.

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer

K. Jensen, A. Gutin, V. Abkevich, 2018, Breast Cancer Research and Treatment.

Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer

L. Pusztai, A. Gutin, J. Reid, 2016, Clinical Cancer Research.

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Z. Szallasi, G. Mills, E. Winer, 2016, Clinical Cancer Research.

Homologous Recombination De fi ciency ( HRD ) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Z. Szallasi, G. Mills, E. Winer, 2016 .

Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

Alexander Gutin, Victor Abkevich, Michael Perry, 2014, Breast Cancer Research.

Predisposition locus for major depression at chromosome 12q22-12q23.2.

M. Skolnick, N. Camp, L. Cannon-Albright, 2003, American journal of human genetics.

Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression

M. Skolnick, J. Potter, A. Gutin, 2009, Molecular Psychiatry.

Abstract P5-06-01: Homologous recombination deficiency (HRD) score predicts response to standard neoadjuvant chemotherapy in patients with triple negative or BRCA1/2 mutation-associated breast cancer

Kirstin C. Jensen, A. Gutin, V. Abkevich, 2015 .

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis

A. Richardson, W. Gradishar, J. Garber, 2019, Clinical Cancer Research.

Combined Homologous Recombination Deficiency (HRD) scores and response to neoadjuvant platinum-based chemotherapy in triple-negative and/or BRCA1/2 mutation-associated breast cancer.

G. Mills, A. Gutin, J. Reid, 2015 .

Abstract P3-06-11: Homologous recombination deficiency (HRD) assay predicts response to cisplatin neoadjuvant chemotherapy in patients with triple negative breast cancer

Z. Szallasi, E. Winer, A. Richardson, 2015 .

The Myxoma Virus M-T5 Ankyrin Repeat Host Range Protein Is a Novel Adaptor That Coordinately Links the Cellular Signaling Pathways Mediated by Akt and Skp1 in Virus-Infected Cells

G. McFadden, J. Lanchbury, M. Dufford, 2009, Journal of Virology.

The Myxoma Virus MT 5 Ankyrin Repeat Host Range Protein Is a Novel Adaptor That Coordinately Links the Cellular Signaling Pathways Mediated by Akt and Skp 1 in Virus-Infected Cells

G. McFadden, J. Lanchbury, M. Dufford, 2009 .

The Human-Bacterial Pathogen Protein Interaction Networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis

T. M. Murali, Josep Bassaganya-Riera, Corban G. Rivera, 2010, PloS one.

Linkage of body mass index to chromosome 20 in Utah pedigrees

Alun Thomas, A. Gutin, S. Hunt, 2001, Human Genetics.

A major predisposition locus for severe obesity, at 4p15-p14.

M. Skolnick, A. Gutin, S. Hunt, 2002, American journal of human genetics.

TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition.

Steven C Hunt, Alexander Gutin, Victor Abkevich, 2006, Human molecular genetics.

Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.

K. Baggerly, A. Sood, R. Broaddus, 2016 .

884PDNEXT GENERATION SEQUENCING OF BRCA1/2 IN HIGH GRADE OVARIAN TUMORS EXPANDS BRCA DEFECTS BEYOND GERMLINE MUTATIONS.

A. Gutin, M. Munsell, J. Lanchbury, 2014, Annals of Oncology.

Suggestive evidence on chromosomes 2 and 19 for HTR1A-independent linkage of genes to major depression

V. Abkevich, D. Shattuck, D. Katz, 2010, neurogenetics.

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer

K. Jensen, A. Gutin, V. Abkevich, 2018, Breast Cancer Research and Treatment.

Variants in Apaf-1 segregating with major depression promote apoptosome function

Jean M. Severin, T. Holzman, V. Abkevich, 2006, Molecular Psychiatry.

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

A. Richardson, A. Gutin, M. Goetz, 2023, Breast Cancer Research and Treatment.